Compound Evidence File
#EC-2026-0461
Vitamin B12 1mg/ml
Filed under Injectable Oils. The bureau holds 151 laboratory returns for this compound from 53 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
53 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 10.0 | 10.0 | 9 Jan 2026 | 5 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 10.0 | 9.9 | 10.0 | 27 Mar 2026 | 4 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 10.0 | 10.0 | 10.0 | 27 Dec 2025 | 19 May 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 21 Jan 2026 | 13 Mar 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 26 Nov 2025 | 5 Jul 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 10.0 | 10.0 | 25 Mar 2026 | 23 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Feb 2026 | 14 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 10 May 2026 | 2 Aug 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Jan 2026 | 7 Mar 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 28 Jan 2026 | 8 Mar 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Dec 2025 | 12 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 9.9 | 9.9 | 9.9 | 2 May 2026 | 11 Jul 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 3 Jan 2026 | 5 Aug 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 6 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Dec 2025 | 9 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 2 Apr 2026 | 19 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Feb 2026 | 18 Feb 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 25 Feb 2026 | 10 Mar 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 9.9 | 9.9 | 9.9 | 21 Dec 2025 | 7 Apr 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 9.9 | 27 Dec 2025 | 14 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 2 | 9.9 | 9.9 | 9.9 | 12 Feb 2026 | 12 Aug 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.8 | 8.1 | 9.5 | 21 May 2026 | 21 May 2026 |
| Shenzhen Jiechuang TradingCASE #VI-2026-0292 | X | 1 | 8.7 | 8.7 | 8.7 | 21 May 2025 | 21 May 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.7 | 8.7 | 8.7 | 2 Apr 2025 | 2 Apr 2025 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 8.6 | 8.6 | 8.6 | 3 Jun 2025 | 3 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.5 | 7.1 | 9.7 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 8.5 | 7.9 | 9.6 | 24 May 2026 | 24 May 2026 |
| TCICASE #VI-2026-0650 | X | 1 | 8.4 | 8.4 | 8.4 | 3 Jul 2025 | 3 Jul 2025 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 8.4 | 8.4 | 8.4 | 14 Jan 2025 | 14 Jan 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 8 | 8.3 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 8.1 | 8.1 | 8.1 | 21 May 2025 | 21 May 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 7.9 | 7.9 | 7.9 | 13 Jun 2025 | 13 Jun 2025 |
| Precision Peptide CoCASE #VI-2026-0559 | X | 2 | 7.8 | 6.1 | 9.5 | 13 Jun 2025 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 7.7 | 6.8 | 8.2 | 24 May 2026 | 24 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 7.7 | 7.7 | 7.7 | 21 May 2025 | 21 May 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 | 13 Jun 2025 |
| Heman Peptide HMCASE #VI-2026-0089 | X | 1 | 7.4 | 7.4 | 7.4 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 | 11 Jun 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 1 | 7.0 | 7.0 | 7.0 | 2 Apr 2025 | 2 Apr 2025 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 6.9 | 5.8 | 8.1 | 8 Jul 2025 | 24 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 10 | 6.7 | 4.7 | 9.5 | 17 Dec 2024 | 24 May 2026 |
| Peptide SciencesCASE #VI-2026-0867 | X | 12 | 6.5 | 4.1 | 8.8 | 27 Feb 2025 | 23 May 2026 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 5.6 | 5.6 | 5.6 | 6 May 2025 | 6 May 2025 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 5.5 | 5.5 | 5.5 | 2 Jul 2025 | 2 Jul 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.7 | 4.7 | 4.7 | 3 Jul 2025 | 3 Jul 2025 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 1 | 4.4 | 4.4 | 4.4 | 17 Dec 2024 | 17 Dec 2024 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 4.1 | 4.1 | 4.1 | 11 Jun 2025 | 11 Jun 2025 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 1.9 | 1.9 | 1.9 | 2 Apr 2025 | 2 Apr 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 1.0 | 1.0 | 1.0 | 16 Mar 2025 | 16 Mar 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for Vitamin B12 1mg/ml alone.